Smoking induces glomerulosclerosis in aging estrogen-deficient mice through cross-talk between TGF-β1 and IGF-I signaling pathways

Journal of the American Society of Nephrology

Volumn 17, Issue 12, 2006, Pages 3315-3324

  Elliot, Sharon J ^a   Karl, Michael ^a   Berho, Mariana ^a   Xia, Xiaomei ^a   Pereria Simon, Simone ^a   Espinosa Heidmann, Diego ^a   Striker, Gary E ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ALBUMIN; CIGARETTE SMOKE; COLLAGEN TYPE 4; CREATININE; ESTRADIOL; ESTROGEN; MESSENGER RNA; NEUTRALIZING ANTIBODY; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PLACEBO; PROTEIN KINASE B; SMAD PROTEIN; SMAD3 PROTEIN; SOMATOMEDIN C; SOMATOMEDIN C ANTIBODY; SOMATOMEDIN C RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

AGING; ALBUMINURIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL ISOLATION; CHRONIC KIDNEY DISEASE; CIGARETTE SMOKING; CONTROLLED STUDY; CREATININE URINE LEVEL; DATA BASE; DRUG IMPLANT; DRUG PELLET; ENZYME LINKED IMMUNOSORBENT ASSAY; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; FEMALE; GENE CONSTRUCT; GENE EXPRESSION; GLOMERULOSCLEROSIS; GLOMERULUS; HEART WEIGHT; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; KIDNEY FAILURE; KIDNEY MASS; MESANGIUM CELL; MOLECULAR INTERACTION; MOUSE; NONHUMAN; OVARIECTOMY; PATHOGENESIS; PHENOTYPE; POSTMENOPAUSE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RISK FACTOR; SIGNAL TRANSDUCTION; UNITED STATES; URINARY EXCRETION;

EID: 33845249305     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2006070799     Document Type: Article

References (51)

1. Orth SR, Ritz E: The renal risks of smoking: An update. Curr Opin Nephrol Hypertens 11: 483-488, 2002
2. Orth SR: Effects of smoking on systemic and intrarenal hemodynamics: Influence on renal function. J Am Soc Nephrol 15[Suppl 1]: S58-S63, 2004
3. Briganti EM, Branley P, Chadban SJ, Shaw JE, McNeil JJ, Welborn TA, Atkins RC: Smoking is associated with renal impairment and proteinuria in the normal population: The AusDiab kidney study. Australian Diabetes, Obesity and Lifestyle Study. Am J Kidney Dis 40: 704-712, 2002
4. Chase HP, Garg SK, Marshall G, Berg CL, Harris S, Jackson WE, Hamman RE: Cigarette smoking increases the risk of albuminuria among subjects with type I diabetes. JAMA 265: 614-617, 1991
5. Corradi L, Zoppi A, Tettamanti F, Malamani G, Lazzari P, Fogari R: Association between smoking and micro-albuminuria in hypertensive patients with type 2 diabetes mellitus. J Hypertens Suppl 11: S190-S191, 1993
6. Ward MM, Studenski S: Clinical prognostic factors in lupus nephritis. The importance of hypertension and smoking. Arch Intern Med 152: 2082-2088, 1992
7. Hu J, Ugnat AM: Active and passive smoking and risk of renal cell carcinoma in Canada. Eur J Cancer 41: 770-778, 2005
8. Mahabir S, Leitzmann MF, Virtanen MJ, Virtamo J, Pietinen P, Albanes D, Taylor PR: Prospective study of alcohol drinking and renal cell cancer risk in a cohort of Finnish male smokers. Cancer Epidemiol Biomarkers Prev 14: 170-175, 2005
9. US Renal Data System: USRDS 2000 Annual Data Report, 2nd Ed., Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2000
10. Haroun MK, Jaar BG, Hoffman SC, Comstock GW, Klag MJ, Coresh J: Risk factors for chronic kidney disease: A prospective study of 23,534 men and women in Washington County, Maryland. J Am Soc Nephrol 14: 2934-2941, 2003
11. Orth SR, Stockmann A, Conradt C, Ritz E, Ferro M, Kreusser W, Piccoli G, Rambausek M, Roccatello D, Schafer K, Sieberth HG, Wanner C, Watschinger B, Zucchelli P: Smoking as a risk factor for end-stage renal failure in men with primary renal disease. Kidney Int 54: 926-931, 1998
12. Orth SR, Ritz E: Adverse effect of smoking on renal function in the general population: Are men at higher risk? Am J Kidney Dis 40: 864-866, 2002
13. Stengel B, Couchoud C, Cenee S, Hemon D: Age, blood pressure and smoking effects on chronic renal failure in primary glomerular nephropathies. Kidney Int 57: 2519-2526, 2000
14. Zeier M, Gafter U, Ritz E: Renal function and renal disease in males or females: Vive la petite difference. Nephrol Dial Transplant 13: 2195-2198, 1998
15. Fornoni A, Rosenzweig SA, Lenz O, Rivera A, Striker GE, Elliot SJ: Low insulin-like growth factor binding protein-2 expression is responsible for increased insulin receptor substrate-1 phosphorylation in mesangial cells from mice susceptible to glomerulosclerosis. Endocrinology 147: 3547-3554, 2006
16. Schnaper HW, Hayashida T, Hubchak SC, Poncelet AC: TGF-beta signal transduction and mesangial cell fibrogenesis. Am J Physiol Renal Physiol 284: F243-F252, 2003
17. Ziyadeh FN: Mediators of diabetic renal disease: The case for TGF-beta as the major mediator. J Am Soc Nephrol 15[Suppl 1]: S55-S57, 2004
18. Karl M, Berho M, Pignac-Kobinger J, Striker GE, Elliot SJ: Differential effects of continuous and intermittent 17beta-estradiol replacement and tamoxifen therapy on the prevention of glomerulosclerosis: Modulation of the mesangial cell phenotype in vivo. Am J Pathol 169: 351-361, 2006
19. Witschi H: Successful and not so successful chemoprevention of tobacco smoke-induced lung tumors. Exp Lung Res 26: 743-755, 2000
20. Elliot SJ, Karl M, Berho M, Potier M, Zheng F, LeClercq B, Striker GE, Striker L: Estrogen deficiency accelerates progression of glomerulosclerosis in susceptible mice. Am J Pathol 162: 1441-1448, 2003
21. He CJ, Esposito C, Phillips C, Zalups RK, Henderson DA, Striker GE, Striker LJ: Dissociation of glomerular hypertrophy, cell proliferation and glomerulosclerosis in mouse strains heterozygous for a mutation (Os) which induces a 50% reduction in nephron number. J Clin Invest 97: 1-8, 1996
22. Elliot SJ, Striker LJ, Hattori M, Yang CW, He CJ, Peten EP, Striker GE: Mesangial cells from diabetic NOD mice constitutively secrete increased amounts of insulin-like growth factor-I. Endocrinology 133: 1783-1788, 1993
23. Karl M, Potier M, Schulman IH, Rivera A, Werner H, Fornoni A, Elliot SJ: Autocrine activation of the local insulin-like growth factor I system is up-regulated by estrogen receptor (ER)-independent estrogen actions and accounts for decreased ER expression in type 2 diabetic mesangial cells. Endocrinology 146: 889-900, 2005
24. Tack I, Elliot SJ, Potier M, Rivera A, Striker GE, Striker LJ: Autocrine activation of the IGF-I signaling pathway in mesangial cells isolated from diabetic NOD mice. Diabetes 51: 182-188, 2002
25. Benowitz NL, Lessov-Schlaggar CN, Swan GE, Jacob P 3rd: Female sex and oral contraceptive use accelerate nicotine metabolism. Clin Pharmacol Ther 79: 480-488, 2006
26. Orth SR: Smoking: A risk factor for progression of renal disease. Kidney Blood Press Res 23: 202-204, 2000
27. Orth SR, Schroeder T, Ritz E, Ferrari P: Effects of smoking on renal function in patients with type 1 and type 2 diabetes mellitus. Nephrol Dial Transplant 20: 2414-2419, 2005
28. Zheng F, Plati AR, Potier M, Schulman Y, Berho M, Banerjee A, LeClercq B, Zisman A, Striker LJ, Striker GE: Resistance to glomerulosclerosis in B6 mice disappears after menopause. Am J Pathol 162: 1339-1348, 2003
29. Zheng F, Cheng QL, Plati AR, Ye SQ, Berho M, Banerjee A, Potier M, Jaimes EA, Yu H, Guan YF, Hao CM, Striker LJ, Striker GE: The glomerulosclerosis of aging in females: Contribution of the proinflammatory mesangial cell phenotype to macrophage infiltration. Am J Pathol 165: 1789-1798, 2004
30. Pryor WA: Cigarette smoke radicals and the role of free radicals in chemical carcinogenicity. Environ Health Perspect 105[Suppl 4]: 875-882, 1997
31. Church DF, Pryor WA: Free-radical chemistry of cigarette smoke and its toxicological implications. Environ Health Perspect 64: 111-126, 1985
32. Kohler KA, McClellan WM, Ziemer DC, Kleinbaum DG, Boring JR: Smoking and microalbuminuria: A case-control study in African-Americans with type 2 diabetes. Diabetes Care 25: 243-245, 2002
33. Nilsson PM, Gudbjornsdottir S, Eliasson B, Cederholm J: Smoking is associated with increased HbA1c values and microalbuminuria in patients with diabetes: Data from the National Diabetes Register in Sweden. Diabetes Metab 30: 261-268, 2004
34. Scott LJ, Warram JH, Hanna LS, Laffel LM, Ryan L, Krolewski AS: A nonlinear effect of hyperglycemia and current cigarette smoking are major determinants of the onset of microalbuminuria in type 1 diabetes. Diabetes 50: 2842-2849, 2001
35. vom Saal FS, Finch CE, Nelson JF: Natural history and mechanisms of reproductive aging in humans, laboratory rodents, and other selected vertebrates. In: The Physiology of Reproduction, 2nd Ed., edited by Knobil E, Neill JD, New York, Raven Press, 1994, pp 1213-1314
36. Odoni G, Ogata H, Viedt C, Amann K, Ritz E, Orth SR: Cigarette smoke condensate aggravates renal injury in the renal ablation model. Kidney Int 61: 2090-2098, 2002
37. Ritz E: Heart and kidney: Fatal twins? Am J Med 119[Suppl 1]: S31-S39, 2006
38. Chen S, Iglesias-De La Cruz MC, Jim B, Hong SW, Isono M, Ziyadeh FN: Reversibility of established diabetic glomerulopathy by anti-TGF-B antibodies in db/db mice. Biochem Biophys Res Commun 300: 16-22, 2002
39. Iglesias-De La Cruz MC, Ruiz-Torres P, Alcami J, Diez-Marques L, Ortega-Velazquez R, Chen S, Rodriguez-Puyol M, Ziyadeh FN, Rodriguez-Puyol D: Hydrogen peroxide increases extracellular matrix mRNA through TGF-beta in human mesangial cells. Kidney Int 59: 87-95, 2001
40. Mur C, Claria J, Rodela S, Lario S, Campistol JM, Titos E, Inigo P, Cases A, Abian J, Esmatjes E: Cigarette smoke concentrate increases 8-epi-PGF2alpha and TGFbeta1 secretion in rat mesangial cells. Life Sci 75: 611-621, 2004
41. Yang CW, Hattori M, Vlassara H, He CJ, Carome MA, Yamato E, Elliot S, Striker GE, Striker LJ: Overexpression of transforming growth factor-beta 1 mRNA is associated with up-regulation of glomerular tenascin and laminin gene expression in nonobese diabetic mice. J Am Soc Nephrol 5: 1610-1617, 1995
42. Matsuda T, Yamamoto T, Muraguchi A, Saatcioglu F: Cross-talk between transforming growth factor-beta and estrogen receptor signaling through Smad3. J Biol Chem 276: 42908-42914, 2001
43. Delafontaine P, Ku L: Reactive oxygen species stimulate insulin-like growth factor I synthesis in vascular smooth muscle cells. Cardiovasc Res 33: 216-222, 1997
44. Liu C, Lian F, Smith DE, Russell RM, Wang XD: Lycopene supplementation inhibits lung squamous metaplasia and induces apoptosis via up-regulating insulin-like growth factor-binding protein 3 in cigarette smoke-exposed ferrets. Cancer Res 63: 3138-3144, 2003
45. Blush J, Lei J, Ju W, Silbiger S, Pullman J, Neugarten J: Estradiol reverses renal injury in Alb/TGF-beta1 transgenic mice. Kidney Int 66: 2148-2154, 2004
46. Maric C, Sandberg K, Hinojosa-Laborde C: Glomerulosclerosis and tubulointerstitial fibrosis are attenuated with 17beta-estradiol in the aging Dahl salt sensitive rat. J Am Soc Nephrol 15: 1546-1556, 2004
47. Hayashida T, Poncelet AC, Hubchak SC, Schnaper HW: TGF-beta1 activates MAP kinase in human mesangial cells: A possible role in collagen expression. Kidney Int 56: 1710-1720, 1999
48. Hayashida T, Decaestecker M, Schnaper HW: Cross-talk between ERK MAP kinase and Smad signaling pathways enhances TGF-beta-dependent responses in human mesangial cells. FASEB J 17: 1576-1578, 2003
49. Runyan CE, Schnaper HW, Poncelet AC: The phosphatidylinositol 3-kinase/Akt pathway enhances Smad3-stimulated mesangial cell collagen I expression in response to transforming growth factor-beta1. J Biol Chem 279: 2632-2639, 2004
50. Stoica A, Saceda M, Fakhro A, Solomon HB, Fenster BD, Martin MB: The role of transforming growth factor-beta in the regulation of estrogen receptor expression in the MCF-7 breast cancer cell line. Endocrinology 138: 1498-1505, 1997
51. Scheidegger KJ, Cenni B, Picard D, Delafontaine P: Estradiol decreases IGF-1 and IGF-1 receptor expression in rat aortic smooth muscle cells. Mechanisms for its atheroprotective effects. J Biol Chem 275: 38921-38928, 2000